在急性冠状动脉综合征中患有糖尿病
Panagiota K Stampouloglou1, Artemis Anastasiou1, Evanthia Bletsa1
13rd Department of Cardiology, Thoracic Diseases General Hospital "Sotiria", National and Kapodistrian University of Athens, 11527 Athens, Greece.
Life (Basel, Switzerland)
|November 25, 2023
概括
糖尿病 (DM) 复杂化了急性冠状动脉综合征 (ACS) 的结果. 非胰岛素疗法对这些患者的心血管风险管理有希望,但需要更多的研究.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病是一种全球性流行病,与严重的微血管和宏血管并发症有关,包括冠状动脉疾病 (CAD).
- 患有急性冠状动脉综合征 (ACS) 和DM的患者由于胰岛素抵抗,高血糖和内皮功能障碍等机制,预后较差.
- 在糖尿病患者心肌梗塞期间,最佳的再注射策略和血糖控制仍然具有挑战性.
研究的目的:
- 审查将DM和ACS联系在一起的病理生理机制.
- 评估糖尿病患者中ACS目前的治疗策略.
- 探索新型非胰岛素疗法的潜力,以管理DM中心血管风险.
主要方法:
- 关于糖尿病,急性冠状动脉综合征和心血管结果的现有文献的审查.
- 对导致不良结果的病理生理机制的分析.
- 评估当前和新兴的治疗策略,包括手术 vs. 皮肤间干预和药理疗法.
主要成果:
- 在复杂的冠状动脉解剖学中,对于患有DM的ACS患者来说,冠状动脉旁路手术可能优先于穿皮冠状动脉干预.
- 严格的血糖控制,避免高血糖和低血糖,在心肌梗塞的急性阶段至关重要.
- 非胰岛素疗法,如GLP-1受体激活剂,DPP-4抑制剂和SGLT-2抑制剂,提供潜在的心血管益处,降低低血糖的风险.
结论:
- 在DM患者中,ACS的最佳治疗策略仍在发展.
- 非胰岛素疗法为糖尿病患者的心血管风险管理提供了一个有希望的途径,因为它们具有多因素的保护作用和低低血糖风险.
- 需要从随机对照试验中获得进一步的强有力的证据,以确认新型非胰岛素抗糖尿病药物在这个人群中的益处.
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
126
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
126
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289


